Phase I/II study of ABT-378/ritonavir [lopinavir/ritonavir] in combination with reverse transcriptase inhibitors in antiretroviral naive HIV-infected patients
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2008
At a glance
- Drugs Lamivudine; Lopinavir/ritonavir; Stavudine
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 02 Apr 2008 Added affiliate, from clinicaltrials.gov record.
- 02 Apr 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
- 11 Oct 2005 New trial record.